Open AccessLongitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA
Author(s) -
Steffen Dietz,
Petros Christopoulos,
Zhao Yuan,
Arlou Kristina Angeles,
Lisa Gu,
AnnaLena Volckmar,
Simon J. Ogrodnik,
Florian Janke,
Chiara Dalle Fratte,
Tomasz Żemojtel,
Marc A. Schneider,
Daniel Kazdal,
Volker Endris,
Michael Meister,
Thomas Muley,
Erika Cecchin,
Martin Reck,
Matthias Schlesner,
Michael Thomas,
Albrecht Stenzinger,
Holger Sültmann
Publication year - 2020
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.596
H-Index - 63
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2020.103103
Subject(s) - copy number variation , targeted therapy , lung cancer , medicine , non small cell lung cancer (nsclc) , cancer research , oncology , biology , cancer , gene , genetics , genome , a549 cell
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom